Literature DB >> 25329490

Susceptibility testing of the polymyxins: where are we now?

Romney M Humphries1.   

Abstract

Antimicrobial susceptibility testing for the polymyxins-colistin and polymyxin B-is fraught with technical challenges. Key among these is the propensity of the polymyxins to adsorb to polystyrene, a material often used for in vitro minimum inhibitory concentration testing devices. This effect may be mitigated by the addition of a surfactant such as polysorbate 80; however, concern exists that polysorbate 80 may act synergistically with the polymyxins and artificially lower minimum inhibitory concentrations. Furthermore, the polymyxins diffuse poorly through agar, compromising the performance of both disk diffusion and Etest methods. Very few peer-reviewed studies have investigated in vitro susceptibility test methods for the polymyxins, and it is clear that an in vitro test that reliably predicts the activity of the polymyxins in vivo has yet to be defined. This review describes the methods available and challenges associated with susceptibility testing of colistin and polymyxin B and discusses the current breakpoints for both agents.
© 2014 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  broth microdilution; polymyxins; susceptibility testing

Mesh:

Substances:

Year:  2014        PMID: 25329490     DOI: 10.1002/phar.1505

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  41 in total

1.  In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.

Authors:  Natália Barth; Vanessa B Ribeiro; Alexandre P Zavascki
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

2.  Evaluation of the MicroScan Colistin Well and Gradient Diffusion Strips for Colistin Susceptibility Testing in Enterobacteriaceae.

Authors:  Joseph D Lutgring; Anny Kim; Davina Campbell; Maria Karlsson; Allison C Brown; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

Review 3.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 4.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

5.  The Search for a Practical Method for Colistin Susceptibility Testing: Have We Found It by Going Back to the Future?

Authors:  Michael J Satlin
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

6.  Rapid Detection of Polymyxin-Resistant Enterobacteriaceae from Blood Cultures.

Authors:  Aurélie Jayol; Véronique Dubois; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2016-06-15       Impact factor: 5.948

Review 7.  Is it time to move away from polymyxins?: evidence and alternatives.

Authors:  Rajeev Soman; Yamuna Devi Bakthavatchalam; Abinaya Nadarajan; Hariharan Triplicane Dwarakanathan; Ramasubramanian Venkatasubramanian; Balaji Veeraraghavan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-02       Impact factor: 3.267

8.  Challenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing.

Authors:  Yamuna Devi Bakthavatchalam; Balaji Veeraraghavan
Journal:  J Clin Diagn Res       Date:  2017-08-01

9.  Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?

Authors:  Shawn Vasoo
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

10.  High-Level Resistance to Colistin Mediated by Various Mutations in the crrB Gene among Carbapenemase-Producing Klebsiella pneumoniae.

Authors:  Aurélie Jayol; Patrice Nordmann; Adrian Brink; Maria-Virginia Villegas; Véronique Dubois; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.